Skip to main content
Equibles

TORONTO DOMINION BANK

Bank

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 947263 TORONTO, ONTARIO, A6
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$32,115,323
-$3,678,924 QoQ
Shares Held
510,253
0.0% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Derivatives in TARS

reported options exposure · as of Jun 30, 2026
CallValue
$2,958,180
CallShares
47,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TORONTO DOMINION BANK holds $769,394,627 across 59 Biotechnology names. TARS ranks #6 (4.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PTCT
Ptc Therapeutics, Inc.
 2,165,846 $176,668,057
2 CELC
Celcuity Inc.
 1,258,758 $131,691,261
3 STOK
Stoke Therapeutics, Inc.
 3,173,258 $103,829,001
4 MDGL
Madrigal Pharmaceuticals, Inc.
 181,432 $97,419,912
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 85,391 $42,416,270
6 TARS
Tarsus Pharmaceuticals, Inc.
This page 		510,253 $32,115,323
7 REGN
Regeneron Pharmaceuticals, Inc.
 48,783 $30,418,151
8 NGNE
Neurogene Inc.
 681,337 $21,428,048

All Filings in TARS

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,958,180 47,000
2026-06-30 $32,115,323 510,253
2026-03-31 $35,794,247 510,253
2025-12-31 $41,779,515 510,253
2025-09-30 $36,702,957 617,583
2025-06-30 $40,589,480 1,001,962
2025-03-31 $96,305,650 1,874,745
2024-12-31 $105,713,954 1,909,228